Analysis of tumor-associated immune cell infiltrates showed that the treatment led to reduction of Tregs, influx of M1-like macrophages, increased infiltration of CD8+ T cells, and increased T effector to T regulatory cell ratios. This evidence concerns the gene CD8A and neoplasm.